Ownership

13F as of Q2 2026 · 69.6M shares outstanding

Who owns MDNAF?

By type of holder

Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

No insider has filed a notice of proposed sale (Form 144) for Medicenna Therapeutics Corp in the last 12 months.

There are not yet two fiscal years of reported share counts for Medicenna Therapeutics Corp.

No 13F manager reports holding MDNAF.

Investment managers reporting MDNAF on Form 13F

No 13F manager reports holding MDNAF yet.

Mutual funds and ETFs reporting MDNAF on Form N-PORT; together they hold 0.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FN Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust	$12.6K	34.1K	0.05%	0.00%	August 31, 2023

Fidelity Concord Street Trust

Position value

$12.6K

% of company

0.05%

% of the fund

0.00%

As of

August 31, 2023

Comments